Efficacy of Low Dose Naltrexone in Psoriasis
Low dose naltrexone is an effective therapy for psoriasis as in other chronic dermatological diseases. It is a cost-effective therapy with few tolerable side-effects. It requires further studies for long-term response.
STUDY: Ivermectin linked to "large reductions" in COVID deaths.
A new paper published in the American Journal of Therapeutics suggests that use of the antiparasitic drug ivermectin could lead to “large reductions” in deaths among people who test “positive” for the Wuhan coronavirus (Covid-19).
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings
During July 2021, 469 cases of COVID-19 associated with multiple summer events and large public gatherings in a town in Barnstable County, Massachusetts, were identified among Massachusetts residents.
Chronic Fatigue Study Unlocks LDN’s Beneficial Mechanisms
Inspired by reports from patients about improved Chronic Fatigue (CFS) symptoms after starting low dose naltrexone, a group of Australian and Japanese researchers decided to explore the mechanism by which these patients were experiencing benefits from LDN.
IV Ascorbic Acid for Critical Illness
Numerous studies of the profound physiologic and clinical impacts of intravenous ascorbic acid (AA) in critical illness states have been published over the past two decades.
Natural Immunity Longer Lasting Than Protection From COVID-19 Vaccines: Dr. Robert Malone
The immunity conferred by recovering from COVID-19 is better than the protection afforded by COVID-19 vaccines, a prominent vaccine inventor says, citing in part a recent study from Israel.